GAMBRO: TO PURCHASE U.S. DIALYSIS CENTERS
Gambro, a Swedish health care company, will buy Vivra, aThis is part of the California Healthline Daily Edition, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
California company that operates more than 262 dialysis centers
in 28 states, for $1.6 billion, FINANCIAL TIMES reports. Gambro,
a manufacturer of components and pharmaceuticals for dialysis
machinery, "already owns a chain of dialysis clinics in the
U.S.," but the deal will more than double its current capacity to
26,000 patients, making it the second-largest provider of
dialysis services in the country. FINANCIAL TIMES reports that
the move is "unusual," as Gambro is purchasing a customer rather
than a competitor. Mikael Lilius, CEO of Incentive, Gambro's
parent company, addressed concerns that the company may dictate
its customers' needs on commercial rather than medical grounds,
saying that "the patients' well-being took precedence, and less
than half Gambro's existing clinics used Gambro products"